Latest news about Asarfi Hospital
Asarfi Hospital
213.80
-1.20(-0.56%)
Company Performance:
View Company Insights1D-0.56%
1M+0.02%
6M+35.49%
1Y+73.82%
5Y0.00%
More news about Asarfi Hospital
30May 26
Asarfi Hospital FY26 PAT rises 58% to INR16.7 crores
Asarfi Hospital Limited reported a 58% year-on-year increase in profit after tax to INR16.7 crores for FY26, supported by a 42% rise in revenue to INR173.5 crores. Q4 revenue grew 29% to INR45.2 crores. The company plans to expand bed capacity to 500-plus by 2028, targeting INR400 crores revenue and improved margins.
12May 26
Asarfi Hospital Reports 42% FY26 Revenue Growth; Audited Results Published in National Newspapers
Asarfi Hospital Limited reported strong FY26 performance with 42% YoY revenue growth to ₹173.5 Cr, 58% PAT growth to ₹16.7 Cr, and 20% EBITDA margins. The Board approved audited standalone and consolidated results on May 11, 2026, subsequently published in The Times of India and Dainik Jagran on May 12, 2026 under Regulation 30. Key operational highlights include 46% IPD revenue growth, Cath Lab upgrade, cardiac bed expansion from 25 to 45 beds, and a multi-organ transplant partnership with Gleneagles Hospital, Chennai.
11May 26
Asarfi Hospital Reports FY26 Audited Results: Revenue at ₹17,319.69 Lakhs, Net Profit at ₹1,707.66 Lakhs
Asarfi Hospital Limited reported strong FY26 audited results with standalone revenue from operations at ₹17,319.69 lakhs and net profit after tax at ₹1,707.66 lakhs, up from ₹12,177.76 lakhs and ₹1,097.96 lakhs respectively in the prior year. On a consolidated basis, revenue stood at ₹17,350.29 lakhs and net profit at ₹1,666.09 lakhs. Statutory auditors M/s R. K. Thakkar & Co. issued unmodified audit opinions on both standalone and consolidated financial statements.
09Feb 26
Asarfi Hospital Limited Reports Strong Q3FY26 Results with 40% Revenue Growth
Asarfi Hospital Limited delivered robust Q3FY26 performance with 40% revenue growth to ₹4,605.87 lakhs and 102% net profit increase to ₹548.29 lakhs. The Dhanbad-based healthcare provider demonstrated strong operational momentum with EBITDA margin at 22% and specialty-led growth across cardiology, neurosciences, and oncology segments.
05Dec 25
Asarfi Hospital Reports 50% Revenue Growth, Outlines Vision 2027 Expansion Plan
Asarfi Hospital Limited reported a 50% year-on-year increase in consolidated revenue to ₹80.60 crores, with Profit After Tax rising 70% to ₹7.32 crores. The company announced its Vision 2027, aiming to increase bed capacity to 500, achieve ₹200.00 crores in revenue, and reach 25-27% EBITDA margin. Expansion plans include moving into Bihar and Eastern Uttar Pradesh, introducing advanced services like bone marrow transplants, and integrating education services. Currently, Asarfi operates two hospitals in Dhanbad with 330 beds total.
11Nov 25
Asarfi Hospital Reports Strong Q2 Growth, Secures ₹6.68 Crore Loan for Expansion
Asarfi Hospital Limited reported robust financial results for Q2 and H1 FY2026. Revenue grew 45% YoY to ₹44.85 crore in Q2, and 50% YoY to ₹80.51 crore in H1. EBITDA and PAT margins remained strong. Operational metrics improved, with increased ARPOB and occupancy rates in both super-specialty and cancer units. The company secured funding for expansion, including a ₹4.68 crore term loan for a new Cath Lab and a ₹2 crore bank guarantee limit. A partnership with Gleneagles Chennai aims to establish Jharkhand's first Multi-Organ Transplant Unit. Asarfi Hospital's Vision 2027 targets 500 beds, ₹200 crore in revenues, and improved margins.
Industry Peers
Apollo Hospitals
Max Healthcare Institute
Fortis Healthcare
Global Health
Narayana Hrudayalaya
Aster DM Quality Care
Krishna Institute of Medical Sciences
Dr. Agarwal's Health Care
Rainbow Childrens Medicare
Park Medi World
8,838.50
(+0.44%)
1,014.10
(+0.51%)
926.75
(+1.21%)
1,472.20
(-2.43%)
1,932.10
(+1.49%)
748.40
(-0.85%)
771.00
(+0.33%)
507.80
(+2.25%)
1,442.80
(+0.12%)
290.55
(+0.14%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
